TC Medical(SH:600763) Sou Hu Cai Jing·2025-10-27 12:05Core Viewpoint - Tongce Medical (600763) shows a slight increase in stock price and mixed capital flow, indicating potential investor interest despite some outflows from major and retail investors [1][2]. Group 1: Stock Performance - As of October 27, 2025, Tongce Medical's stock closed at 42.4 yuan, up by 0.9% with a turnover rate of 1.05% and a trading volume of 47,000 hands, resulting in a transaction amount of 199 million yuan [1]. - The capital flow data on October 27 indicates a net outflow of 6.28 million yuan from major funds, accounting for 3.16% of the total transaction amount, while retail investors saw a net inflow of 6.81 million yuan, representing 3.42% of the total [1][2]. Group 2: Recent Capital Flow Trends - Over the past five days, the stock has experienced varying capital flows, with significant net outflows from major and speculative funds on several days, while retail investors consistently showed net inflows [2]. - On October 24, 2025, the stock price decreased by 0.4%, with major funds experiencing a net outflow of 1.24 million yuan, while retail investors had a net inflow of 1.37 million yuan [2]. Group 3: Financial Performance and Industry Comparison - For the third quarter of 2025, Tongce Medical reported a main business revenue of 2.29 billion yuan, a year-on-year increase of 2.56%, and a net profit attributable to shareholders of 514 million yuan, up by 3.16% [3]. - The company’s total market capitalization is 18.965 billion yuan, with a net asset value of 4.703 billion yuan and a net profit margin of 26.91%, significantly higher than the industry average [3]. - Tongce Medical's financial metrics, including a price-to-earnings ratio of 27.7 and a return on equity (ROE) of 11.8%, position it favorably within the healthcare services sector [3]. Group 4: Analyst Ratings - In the last 90 days, nine institutions have rated Tongce Medical, with seven giving a "buy" rating and two an "accumulate" rating, indicating positive sentiment among analysts [4]. - The average target price set by institutions over the past 90 days is 52.01 yuan, suggesting potential upside from the current trading price [4].